KMT2C and neoplasm: Using an NGS panel of 25 genes (DNMT1, MBD1, TET1, DNMT3A, DNMT3B, EZH2, KDM6A, EP300, JARID1B, CREBBP, HDAC2, SIRT1, SMARCB1, SMARCA2, SMARCA4, ARID1A, ARID2, BRD7, PBRM1, CHD5, CHD7, CHD4, KMT2A, KMT2D and KMT2C), we performed somatic mutation profiling in 135 tumor samples obtained from patients with GC.